Endo International PLC (DELISTED) (ENDPQ:DL)
0.0006
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Endo International Free Cash Flow: 340.77M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 340.77M |
| September 30, 2023 | 332.72M |
| June 30, 2023 | 284.22M |
| March 31, 2023 | -43.81M |
| December 31, 2022 | 79.15M |
| September 30, 2022 | -75.76M |
| June 30, 2022 | -100.22M |
| March 31, 2022 | 250.61M |
| December 31, 2021 | 323.94M |
| September 30, 2021 | -166.90M |
| June 30, 2021 | -299.68M |
| March 31, 2021 | -139.89M |
| December 31, 2020 | -324.08M |
| September 30, 2020 | 197.52M |
| June 30, 2020 | 301.81M |
| March 31, 2020 | 183.08M |
| December 31, 2019 | 34.20M |
| September 30, 2019 | 111.86M |
| June 30, 2019 | 66.67M |
| March 31, 2019 | 50.93M |
| December 31, 2018 | 180.87M |
| September 30, 2018 | 240.72M |
| June 30, 2018 | 326.15M |
| March 31, 2018 | 311.74M |
| December 31, 2017 | 428.33M |
| Date | Value |
|---|---|
| September 30, 2017 | 362.06M |
| June 30, 2017 | 157.53M |
| March 31, 2017 | 595.41M |
| December 31, 2016 | 370.08M |
| September 30, 2016 | 557.22M |
| June 30, 2016 | 600.77M |
| March 31, 2016 | 14.99M |
| December 31, 2015 | -7.241M |
| September 30, 2015 | -145.93M |
| June 30, 2015 | 234.27M |
| March 31, 2015 | 413.13M |
| December 31, 2014 | 252.35M |
| September 30, 2014 | 151.82M |
| June 30, 2014 | 22.44M |
| March 31, 2014 | 14.96M |
| December 31, 2013 | 190.03M |
| September 30, 2013 | 635.18M |
| June 30, 2013 | 573.90M |
| March 31, 2013 | 582.83M |
| December 31, 2012 | 628.36M |
| September 30, 2012 | 465.11M |
| June 30, 2012 | 576.34M |
| March 31, 2012 | 474.76M |
| December 31, 2011 | 640.43M |
| September 30, 2011 | 538.31M |
Free Cash Flow Range, Past 5 Years
-324.08M
Minimum
Dec 2020
340.77M
Maximum
Dec 2023
71.38M
Average
79.15M
Median
Dec 2022
Free Cash Flow Benchmarks
| Alkermes PLC | 394.23M |
| Jazz Pharmaceuticals PLC | 983.48M |
| Medtronic PLC | 4.931B |
| Perrigo Co PLC | 281.10M |
| Iterum Therapeutics PLC | -42.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 115.06M |
| Cash from Investing (Quarterly) | -11.65M |
| Cash from Financing (Quarterly) | -149.76M |
| Free Cash Flow Per Share (Quarterly) | 0.4038 |
| Free Cash Flow to Equity (Quarterly) | 7.484B |
| Free Cash Flow to Firm (Quarterly) | 94.98M |
| Free Cash Flow Yield | 241.5K% |